Company News
Aurobindo's Acrotech Launches ADQUEY Dermatology Drug in US
Acrotech Biopharma launches ADQUEY™, a novel topical PDE4 inhibitor for atopic dermatitis in US markets.
The product enters a US$1.3 billion market and marks Acrotech's entry into US dermatology thera
